Fluticasone Propionate 0.05% / Niacinamide 4%
Product Images NDC 72934-2087

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate 0.05% / Niacinamide 4% (NDC 72934-2087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

W (2 End)

W (2 End)
Label on a white cylindrical container displaying directions for use of FLUTICASONE PROPIONATE 0.05% / NIACINAMIDE 4%. Instructions include applying topically as directed by a physician, washing hands after use, and storage at controlled room temperature (20-25°C). The label lists Sincerus Florida, LLC, Pompano Beach, FL as the labeler with contact information and FDA reporting details.*
FDA Label Image

A (2087 2 Front)

A (2087 2 Front)
FLUTICASONE PROPIONATE 0.05% / NIACINAMIDE 4% cream in a 30gm white container. The label shows the NDC 72934-2087-2 and the product is labeled as a compounded drug made in the USA by Sincerus Florida, LLC. The label features the Sincerus Florida logo with teal and orange colors.*
FDA Label Image

E (2087 2 Middle)

E (2087 2 Middle)
FLUTICASONE PROPIONATE 0.05% / NIACINAMIDE 4% cream in a 30g white container. The label lists active ingredients as Fluticasone Propionate USP 0.05% and Niacinamide USP 4%, with inactive ingredients making up 95.95%. It is labeled Rx only, with a lot number 091056 and manufacture date 01/01/1970. The product is from Sincerus Florida, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.